衰弱作为腹主动脉瘤腔内修复术后主要不良心脑血管事件的预测因素
该回顾性队列研究纳入749例接受EVAR的老年患者,用mFI评估衰弱,发现衰弱与30天及远期MACCE风险显著增加相关,且mFI对MACCE的预测区分能力优于RCRI。
要点
- 衰弱与EVAR术后30天MACCE风险显著增加相关(调整OR 14.53)。
- 衰弱与远期MACCE风险显著增加相关(调整HR 3.37)。
- mFI对MACCE的预测区分能力优于RCRI。
核心结论
- mFI评估的衰弱可作为EVAR术后老年患者短期和远期MACCE的有用预测因素。
- 与RCRI相比,mFI在预测MACCE方面具有更好的区分和重分类能力。
研究设计与样本
- 回顾性队列研究,纳入749例在三级医院接受EVAR的老年患者。
- 主要暴露为mFI评估的衰弱状态,主要结局为30天和远期MACCE。
- 中位随访32.00个月(范围15.00-59.25个月),13例(1.74%)失访。
主要发现
- 749例中134例(17.89%)为衰弱,185例(24.70%)为衰弱前期。
- 衰弱与30天MACCE风险显著增加相关(调整OR 14.53;95%CI 4.59-46.04;P<.0001)。
- 衰弱与ICU住院时间延长相关(调整OR 2.43;95%CI 1.17-5.07;P=.0176)。
- 远期MACCE风险:衰弱前期调整HR 1.71(95%CI 1.12-2.61),衰弱调整HR 3.37(95%CI 1.86-6.10)。
- 考虑死亡为竞争风险时,衰弱与心脑血管事件仍显著相关(调整HR 2.95;95%CI 1.06-8.15);衰弱与全因死亡风险增加相关(调整HR 1.93;95%CI 1.28-2.90)。
关键数值与推荐
- mFI预测30天MACCE的IDI为0.225(95%CI 0.018-0.431;P=.033),NRI为0.225(95%CI 0.023-0.427;P=.029)。
- mFI预测远期MACCE的IDI为0.056(95%CI 0.018-0.128;P=.013),NRI为0.237(95%CI 0.136-0.359;P<.001)。
临床怎么用
- 对拟行EVAR的老年患者,可采用mFI进行衰弱评估以辅助预测术后MACCE风险。
- 衰弱评估可能有助于识别高危患者并优化围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effect of frailty assessed by the modified Frailty Index (mFI) on major adverse cardiac and cerebrovascular events (MACCE) in the elderly patients after endovascular aortic aneurysm repair (EVAR). METHODS: This was a retrospective cohort study of elderly patients who underwent EVAR in a tertiary hospital. The main exposure was frailty status assessed by the mFI. The primary outcomes were 30-day and long-term MACCE. The predictive ability of the mFI was compared with the Revised Cardiac Risk Index (RCRI) using net reclassification improvement (NRI) and integrated discrimination improvement (IDI) statistics. RESULTS: Of 749 participants, 134 (17.89%) were identified as frail and 185 (24.70%) as prefrail. Thirteen patients (1.74%) were lost in follow-up after surgery, and the median length of follow-up was 32.00 months (range, 15.00-59.25 months). Frailty was associated with a significantly increased risk of 30-day MACCE (adjusted odds ratio OR, 14.53; 95% confidence interval [CI], 4.59-46.04; P < .0001) and longer intensive care unit stay (adjusted odds ratio, 2.43; 95% CI, 1.17-5.07; P = .0176). As for long-term outcomes, both frailty and prefrailty were associated significantly increased risks of MACCE after EVAR (prefrail: adjusted hazard ratio [HR] 1.71; 95% CI, 1.12-2.61; frail: adjusted HR, 3.37; 95% CI, 1.86-6.10). When considering death as a competing risk, we also observed a significant association between frailty and cardiac and cerebrovascular events (adjusted HR, 2.95; 95% CI, 1.06-8.15). In addition, frailty was associated with a significantly increased risk of all-cause mortality (adjusted HR, 1.93; 95% CI, 1.28-2.90). Compared with the RCRI, the mFI had better discrimination in predicting 30-day MACCE (IDI: 0.225; 95% CI, 0.018-0.431; P = .033; NRI: 0.225; 95% CI, 0.023-0.427; P = .029) and long-term MACCE (IDI: 0.056; 95% CI, 0.018-0.128; P = .013; NRI: 0.237; 95% CI, 0.136-0.359; P < .001). CONCLUSIONS: Frailty assessed by the mFI may serve as a useful predictor of both short-term and long-term MACCE in elderly patients after EVAR, with improved discrimination and reclassification abilities compared with the RCRI.
引用
- Wang J, Zhao J, Ma Y, et al. Frailty as a predictor of major adverse cardiac and cerebrovascular events after endovascular aortic aneurysm repair. J Vasc Surg. 2021. PMID: 33548426. doi:10.1016/j.jvs.2021.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。